Apellis Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC APLS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

178,888

Value ($000)

4,494

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,494	0.0%	178,888	12/31/2025
2025 Q3	11/14/2025	3,790	0.0%	167,464	9/30/2025
2025 Q2	8/14/2025	5,227	0.0%	301,939	6/30/2025
2025 Q1	5/19/2025	4,869	0.0%	222,634	3/31/2025
2024 Q4	2/14/2025	6,793	0.0%	212,887	12/31/2024
2024 Q3	11/14/2024	5,510	0.0%	191,065	9/30/2024
2024 Q2	8/14/2024	7,986	0.0%	208,184	6/30/2024
2024 Q1	5/15/2024	8,190	0.0%	139,325	3/31/2024
2023 Q4	2/14/2024	8,486	0.0%	141,768	12/31/2023
2023 Q3	11/13/2023	5,552	0.0%	145,946	9/30/2023
2023 Q2	8/11/2023	6,583	0.0%	99,804	6/30/2023
2023 Q1	5/15/2023	6,583	0.0%	99,804	3/31/2023
2022 Q4	2/14/2023	3,883	0.0%	75,086	12/31/2022
2022 Q3	11/14/2022	4,723	0.0%	69,158	9/30/2022
2022 Q2	8/12/2022	15,900	0.0%	351,624	6/30/2022
2022 Q1	5/16/2022	19,823	0.0%	390,140	3/31/2022
2021 Q4	2/14/2022	17,667	0.0%	373,674	12/31/2021
2021 Q3	11/15/2021	6,724	0.0%	203,990	9/30/2021
2021 Q2	8/16/2021	13,431	0.0%	212,515	6/30/2021
2021 Q1	5/14/2021	2,414	0.0%	56,259	3/31/2021
2020 Q4	3/1/2021	3,715	0.0%	64,947	12/31/2020
2020 Q3	11/13/2020	2,017	0.0%	66,855	9/30/2020
2020 Q2	8/14/2020	2,137	0.0%	65,424	6/30/2020
2020 Q1	5/15/2020	1,260	0.0%	47,041	3/31/2020
2019 Q4	2/14/2020	1,113	0.0%	36,351	12/31/2019